Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-663
Closed -$297K 425
2025
Q3
$297K Hold
663
0.03% 345
2025
Q2
$323K Buy
663
+82
+14% +$46.7K 0.04% 363
2025
Q1
$358K Buy
581
+24
+4% +$13.6K 0.05% 208
2024
Q4
$295K Sell
557
-59
-10% -$33.3K 0.04% 268
2024
Q3
$370K Sell
616
-86
-12% -$48.8K 0.05% 276
2024
Q2
$381K Buy
702
+220
+46% +$126K 0.06% 249
2024
Q1
$309K Buy
+482
New +$293K 0.06% 279

Other funds holding CHE

Cynosure Group's CHE Position: Q4 2025 in Review

Cynosure Group sold out of Chemed (CHE) in Q4 2025, closing a stake of 663 shares — an estimated $297K sold.

Cynosure Group first reported a position in CHE in Q1 2024 and held it in 7 quarters. The position peaked at $381K in Q2 2024. 517 funds tracked by Wall St. Rank hold CHE as of Q4 2025.

  • Cynosure Group reported no remaining Chemed position as of Q4 2025 after selling out during the quarter.
  • Cynosure Group sold 663 Chemed shares in Q4 2025, an estimated $297K.
  • Cynosure Group first reported a position in Chemed in Q1 2024 and held it in 7 quarters.
  • Cynosure Group's Chemed position peaked at $381K in Q2 2024.
  • 517 funds tracked by Wall St. Rank held Chemed as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.